AR065916A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIARTHRITIC AGENT, A DRIVING AGENT AND AN ANTI-INFLAMMATORY AGENT - Google Patents
PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIARTHRITIC AGENT, A DRIVING AGENT AND AN ANTI-INFLAMMATORY AGENTInfo
- Publication number
- AR065916A1 AR065916A1 ARP080101371A ARP080101371A AR065916A1 AR 065916 A1 AR065916 A1 AR 065916A1 AR P080101371 A ARP080101371 A AR P080101371A AR P080101371 A ARP080101371 A AR P080101371A AR 065916 A1 AR065916 A1 AR 065916A1
- Authority
- AR
- Argentina
- Prior art keywords
- agent
- pharmaceutical composition
- combination
- active substance
- antiarthritic
- Prior art date
Links
- 239000002260 anti-inflammatory agent Substances 0.000 title abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940124346 antiarthritic agent Drugs 0.000 title 1
- 239000003435 antirheumatic agent Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 abstract 1
- 229920001287 Chondroitin sulfate Polymers 0.000 abstract 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
- 229940059329 chondroitin sulfate Drugs 0.000 abstract 1
- 239000003042 chondroprotective agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 229960001929 meloxicam Drugs 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composicion farmacéutica compuesta por la combinacion sinérgica de un agente ntiartrítico, como lo es el principio activo: Sulfato de Condroitina, un agente condroprotector, como lo es el principio activo: Glucosamina y una agenteantiinflamatorio, como lo es el principio activo: Meloxicam, los cuales se encuentran formulados en una sola unidad de dosificacion para ser administrada por vía oral en forma de polvo para solucion con presentacion en sobres monodosis, mismos queestán indicados para el tratamiento de enfermedades tales como: osteoartritis, artritis reumatoide, artrotis y cualquier otra enfermedad reumática relacionada.A pharmaceutical composition composed of the synergistic combination of an nthiarthritic agent, such as the active substance: Chondroitin sulfate, a chondroprotective agent, such as the active substance: Glucosamine and an anti-inflammatory agent, such as the active substance: Meloxicam, which are formulated in a single dosage unit to be administered orally in powder form for solution with presentation in single-dose sachets, which are indicated for the treatment of diseases such as: osteoarthritis, rheumatoid arthritis, arthrotis and any other rheumatic disease related.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2007003947A MX2007003947A (en) | 2007-04-02 | 2007-04-02 | Pharmaceutical composition comprising the combination of an anti-arthritic agent, a chondro-protecting agent and an anti-inflammatory agent. |
| PCT/MX2008/000010 WO2008120965A1 (en) | 2007-04-02 | 2008-01-29 | Pharmaceutical composition comprising a combination of an anti-arthritic agent, a chondroprotective agent, and an anti-inflammatory agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR065916A1 true AR065916A1 (en) | 2009-07-08 |
Family
ID=39808486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080101371A AR065916A1 (en) | 2007-04-02 | 2008-04-01 | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIARTHRITIC AGENT, A DRIVING AGENT AND AN ANTI-INFLAMMATORY AGENT |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR065916A1 (en) |
| CL (1) | CL2008000963A1 (en) |
| MX (1) | MX2007003947A (en) |
| WO (1) | WO2008120965A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR067447A1 (en) * | 2008-07-03 | 2009-10-14 | Monte Verde S A | A PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION CONTAINING THE ACTIVE PROINCIPIES GLUCOSAMINE AND MELOXICAM AND THE USE OF SUCH ASSOCIATION FOR THE TREATMENT OF OSTEO-ARTICULAR DEGENERATIVE PATHOLOGIES |
| WO2022250523A1 (en) * | 2021-05-26 | 2022-12-01 | Garcia Perez, Miguel Angel | Pharmaceutical kits and products comprising a direct precursor in the formation of glycosaminoglycans and a non-steroidal anti-inflamatory drug as independent compositions, and uses of same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050101563A1 (en) * | 2001-08-14 | 2005-05-12 | Pharmacia Corporation | Method and compositions for the treatment and prevention of pain and inflammation |
| US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
| RU2260432C1 (en) * | 2004-10-12 | 2005-09-20 | Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") | Agent for treatment of articulation diseases |
-
2007
- 2007-04-02 MX MX2007003947A patent/MX2007003947A/en not_active Application Discontinuation
-
2008
- 2008-01-29 WO PCT/MX2008/000010 patent/WO2008120965A1/en not_active Ceased
- 2008-04-01 AR ARP080101371A patent/AR065916A1/en unknown
- 2008-04-02 CL CL200800963A patent/CL2008000963A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007003947A (en) | 2009-02-25 |
| WO2008120965A1 (en) | 2008-10-09 |
| CL2008000963A1 (en) | 2008-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bottegoni et al. | Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis | |
| ES2619309T3 (en) | Sulfated hyaluronic acid for the treatment of degenerative osteoarthritis | |
| PE20130690A1 (en) | TREATMENT OF RHEUMATOID ARTHRITIS WITH A COMBINATION OF LAQUINIMOD AND METOTREXATE | |
| UY33546A (en) | CORTICOSTEROIDS FOR THE TREATMENT OF THE PAIN OF THE JOINTS | |
| CL2012002318A1 (en) | Compounds derived from thieno [2,3-d] pyrimidine, mnk1 and mnk2 kinase inhibitors; pharmaceutical composition; that understands them; and its use in the treatment of metabolic, hematopoietic, neurodegenerative, renal, inflammatory and cancer diseases. | |
| UY32989A (en) | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COPOSITIONS | |
| AR084781A1 (en) | COMPOSITIONS THAT INCLUDE AND METHODS THAT USE INHIBITORS OF THE SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 | |
| CL2008002999A1 (en) | Use of a pharmaceutical composition comprising trns-clomineph to prepare a drug useful in the treatment of reduction of fasting glucose levels in a male. | |
| BR112012016543A2 (en) | Vb-201 Treatment | |
| BRPI0907414A2 (en) | oral dosage form containing at least two medicinal products | |
| AR068820A1 (en) | PHARMACEUTICAL COMPOSITION UNDERSTANDING THE COMBINATION OF VENOTONIC AGENTS AND VASOPROTECTORS FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCY AND USE | |
| AR081082A1 (en) | ORGANIC COMPOSITIONS TO TREAT DISEASES RELATED TO BETA-ENAC | |
| ECSP099734A (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT | |
| AR065916A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIARTHRITIC AGENT, A DRIVING AGENT AND AN ANTI-INFLAMMATORY AGENT | |
| ECSP067074A (en) | DERIVATIVES OF 4-PHENYL-PYRIMIDINE-2-CARBONITRILE | |
| CO6602160A2 (en) | Oral b12 therapy | |
| ECSP10010054A (en) | PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN INHIBITING AGENT OF XANTINO OXIDASA USEFUL FOR THE CONTROL AND TREATMENT OF THE DROP, GOTOUS ARTHRITIS AND RELATED DISEASES | |
| BR112015008964A2 (en) | stable injectable compositions containing diclofenac and thiocolchicoside | |
| BR112013028872A2 (en) | composition for use in the oral treatment of dental infections; pharmaceutical form for oral administration | |
| AR081007A1 (en) | CHARACTERIZED PHARMACEUTICAL COMBINATION BECAUSE IT INCLUDES IBUPROFEN AND L-ARGININA | |
| ECSP10010053A (en) | PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF CONDROITIN AND DIACEREINE SULFATE AND ITS USE IN THE TREATMENT OF OSTEOARTRITIS AND RELATED DISEASES | |
| AR074521A1 (en) | ASSOCIATION OF ACTIVE INGREDIENTS CONTAINING AN ANTI-INFLAMMATORY, NON-STEROID PHARMACO AND A COLCHICOSIDE DERIVATIVE | |
| AR067465A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A BENZODIAZEPINIC AGENT | |
| ES2468665B1 (en) | Pharmaceutical composition of chondroitin sulfate and celecoxib | |
| UY31230A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSION AGENT AND A BENZODIAZEPINIC AGENT, INDICATED FOR THE CONTROL AND TREATMENT OF CONVULSIVE DISORDERS AND EPILEPTIC SYNDROMES. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |